Benoxaprofen induced toxicity in isolated rat hepatocytes.
The toxicity of benoxaprofen, a non-steroidal anti-inflammatory compound was investigated using rat hepatic microsomal and isolated hepatocyte suspensions. In microsomes, benoxaprofen produced a Type I binding spectra and competitively inhibited (ki 380 microM) the oxidative metabolism of aminopyrine. Marked toxicity was observed following incubation of benoxaprofen with isolated hepatocytes from either untreated, phenobarbitone (PB) or 3-methylcholanthrene (3-MC) pretreated male rats. In untreated hepatocytes increases in the intracellular lactate/pyruvate (L/P) ratio and alanine aminotransferase (ALT) release were related to the benoxaprofen concentration and duration of incubation. Alterations in L/P ratio preceded the release of cytosolic ALT and at 4 h a well defined dose-response relationship existed between the benoxaprofen concentration and the observed increases in the L/P ratio and ALT release. Pretreatment of animals with either PB or 3-MC did not affect the temporal nature nor the magnitude of the hepatocyte response to benoxaprofen. In addition, inhibitors of cytochrome P-450 isozymes (SKF-525A, metyrapone and alpha-napthoflavone) were ineffective with regard to modifying the observed toxicity. The results of this study suggest that hepatic cytochrome P-450 mediated metabolism may not be implicated in the toxicity of benoxaprofen in isolated hepatocytes. However, alterations in the cellular redox state and evidence of plasma membrane bleb formation suggest that benoxaprofen may uncouple oxidative phosphorylation and disturb intracellular calcium ion homeostasis.
D000410:Alanine Transaminase / Q000378:metabolism; D000632:Aminopyrine / Q000378:metabolism; D000818:Animals; D002478:Cells, Cultured; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D007773:Lactates / Q000032:analysis; D008099:Liver / Q000032:analysis / Q000166:cytology / Q000187:drug effects*; D008297:Male; D008862:Microsomes, Liver / Q000187:drug effects; D011422:Propionates / Q000009:adverse effects*; D011773:Pyruvates / Q000032:analysis; D019289:Pyruvic Acid; D051381:Rats
D007773:Lactates; D011422:Propionates; D011773:Pyruvates; D000632:Aminopyrine; C011677:benoxaprofen; D019289:Pyruvic Acid; D003577:Cytochrome P-450 Enzyme System; D000410:Alanine Transaminase